Previous close | 102.19 |
Open | 101.95 |
Bid | 95.30 |
Ask | 101.30 |
Strike | 340.00 |
Expiry date | 2024-08-16 |
Day's range | 101.67 - 102.19 |
Contract range | N/A |
Volume | |
Open interest | 8 |
S&P Global's (NYSE: SPGI) second quarter 2024 results will be issued on Tuesday, July 30, 2024 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com.
Investors are in a gambling mood for S&P 500 stocks again. And it's paying off. If you invested $10,000 in January in the top-performing stock in the S&P 500 at the time and reinvested that in each month's top performer, including Caesars Entertainment in June, you'd have $49,604 now, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge.
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.